The Role of Glial Cells in the Pathophysiology of Epilepsy
Cells · 10.01.2025 · 14 (2) · 94
DOI: 10.3390/cells14020094 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 10.01.2025. Verfasst von Filiz Onat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, 34684 Istanbul, Türkiye. Hauptthemen laut MEDLINE: Epilepsy, Neuroglia. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission Horizon Europe Programme under the call HORIZON-WIDERA-2021-ACCESS-03.
Abstract (Originalsprache)
Epilepsy is a chronic neurological disorder marked by recurrent seizures, significantly impacting individuals worldwide. Current treatments are often ineffective for a third of patients and can cause severe side effects, necessitating new therapeutic approaches. Glial cells, particularly astrocytes, microglia, and oligodendrocytes, are emerging as crucial targets in epilepsy management. Astrocytes regulate neuronal homeostasis, excitability, and synaptic plasticity, playing key roles in maintaining the blood–brain barrier (BBB) and mediating neuroinflammatory responses. Dysregulated astrocyte functions, such as reactive astrogliosis, can lead to abnormal neuronal activity and seizure generation. They release gliotransmitters, cytokines, and chemokines that may exacerbate or mitigate seizures. Microglia, the innate immune cells of the CNS, contribute to neuroinflammation, glutamate excitotoxicity, and the balance between excitatory and inhibitory neurotransmission, underscoring their dual role in seizure promotion and protection. Meanwhile, oligodendrocytes, primarily involved in myelination, also modulate axonal excitability and contribute to the neuron–glia network underlying seizure pathogenesis. Understanding the dynamic interactions of glial cells with neurons provides promising avenues for novel epilepsy therapies. Targeting these cells may lead to improved seizure control and better clinical outcomes, offering hope for patients with refractory epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Pharmacology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, 34684 Istanbul, Türkiye.
- Institute of Health Sciences, Department of Neuroscience, Acibadem Mehmet Ali Aydinlar University, 34684 Istanbul, Türkiye.
- Department of Experimental Medicine, Faculty of Medicine, Lund University, 221 00 Lund, Sweden.
- Department of Pharmacology, Faculty of Pharmacy, Istanbul University, 34452 Istanbul, Türkiye.
ORCID-Profile: Filiz Onat, My Andersson, Nihan Çarçak
Förderung
- European Commission Horizon Europe Programme under the call HORIZON-WIDERA-2021-ACCESS-03
Zitieren
APA
Onat, F., Andersson, M., & Çarçak, N. (2025). The Role of Glial Cells in the Pathophysiology of Epilepsy. Cells, 14(2), 94. https://doi.org/10.3390/cells14020094
Vancouver
Onat F, Andersson M, Çarçak N. The Role of Glial Cells in the Pathophysiology of Epilepsy. Cells. 2025;14(2):94. doi:10.3390/cells14020094
BibTeX
@article{Onat2025,
author = {Onat, Filiz and Andersson, My and Çarçak, Nihan},
title = {The Role of Glial Cells in the Pathophysiology of Epilepsy},
journal = {Cells},
year = {2025},
volume = {14},
number = {2},
pages = {94},
doi = {10.3390/cells14020094}
}
EUVIMED